Alembic debuts generic TarcevaErlotinib tablets are indicated for treating metastatic non-small cell lung cancer patients with tumors with specific growth factor mutations. Omnicell makes leadership, organizational changesThe company said the changes are designed to create a more streamlined organization. Lupin gains FDA OK for 2 generics The FDA has approved obeticholic acid tablets, 5 mg and 10 mg, which is a generic of Intercept’s Ocaliva. Fresenius Kabi launches generic Zemuron Rocuronium Bromide injection is part of Fresenius Kabi's +RFID portfolio of smart-labeled medications. Alvotech, Advanz Pharma to commercialize 5 proposed biosimilars in Europe The partnership agreement includes proposed biosimilars to Simponi, Entyvio and three additional early-stage undisclosed biosimilar candidates. Endo to distribute bivalirudin injection in ready-to-use vials Endo will commercialize the product through its Par sterile products business and expects to begin shipping in summer 2023. Celltrion USA obtains FDA nod for Humira biosimilar Yuflyma is FDA-approved to treat eight conditions, including Crohn’s disease and ulcerative colitis. Aurobindo receives nod for generic Millipred Prednisolone tablets are indicated for a wide variety of disorders. Indivior receives FDA nod for Opvee Opvee nasal spray is indicated for the emergency treatment of known or suspected opioid overdose. Otsuka, Lundbeck get FDA OK for new indication for Rexulti Rexulti is now approved for the treatment of agitation associated with dementia due to Alzheimer’s disease. First Previous 77 78 79 80 81 Next Last
